High dose CART peptide induces abnormal EEG activity and behavioral seizures

Neuropeptides

Volumn 42, Issue 2, 2008, Pages 199-204

  Keating, Glenda L ^a   Kuhar, Michael J ^b   Rye, David B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

CART; Dopamine; EEG; Neuropeptides; Seizure

Indexed keywords

COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ARTICLE; BODY POSTURE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSY; INJECTIONS, INTRAVENTRICULAR; MALE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 39849103548     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2007.11.005     Document Type: Article

References (26)

1. Abbott C.R., Rossi M., Wren A.M., Murphy K.G., Kennedy A.R., Stanley S.A., Zollner A.N., Morgan D.G., Morgan I., Ghatei M.A., Small C.J., and Bloom S.R. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 142 8 (2001) 3457-3463
2. Aja S., Robinson B.M., Mills K.J., Ladenheim E.E., and Moran T.H. Fourth ventricular CART reduces food and water intake and produces a conditioned taste aversion in rats. Behav. Neurosci. 116 (2002) 918-921
3. Aja S., Schwartz G.J., Kuhar M.J., and Moran T.H. Intracerebroventricular CART peptide reduces rat ingestive behavior and alters licking microstructure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1613-R1619
4. Chaki S., Kawashima N., Suzuki Y., Shimazaki T., and Okuyama S. Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents. Eur. J. Pharmacol. 464 (2003) 49-54
5. Dominguez G., Vicentic A., Del Giudice E.M., Jaworski J., Hunter R.G., and Kuhar M.J. CART peptides: modulators of mesolimbic dopamine, feeding, and stress. Ann. N.Y. Acad. Sci. 1025 (2004) 363-369
6. Douglass J., McKinzie A.A., and Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15 (1995) 2471-2481
7. Dylag T., Kotlinska J., Rafalski P., Pachuta A., and Silberring J. The activity of CART peptide fragments. Peptides 27 8 (2006) 1926-1933
8. Ekblad E., Kuhar M., Wierup N., and Sundler F. Cocaine- and amphetamine-regulated transcript: distribution and function in rat gastrointestinal tract. Neurogastroenterol. Motil. 15 5 (2003) 545-557
9. Hanson G.R., Jensen M., Johnson M., and White H.S. Distinct features of seizures induced by cocaine and amphetamine analogs. Eur. J. Pharmacol. 377 2-3 (1999) 167-173
10. Kask A., Schioth H.B., Mutulis F., Wikberg J.E., and Rago L. Anorexigenic cocaine- and amphetamine-regulated transcript peptide intensifies fear reactions in rats. Brain Res. 857 1-2 (2000) 283-285
11. Kimmel H.L., Gong W., Vechia S.D., Hunter R.G., and Kuhar M.J. Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. J. Pharmacol. Exp. Ther. 294 (2000) 784-792
12. Koylu E.O., Couceyro P.R., Lambert P.D., Ling N.C., DeSouza E.B., and Kuhar M.J. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J. Neuroendocrinol. 9 11 (1997) 823-833
13. Koylu E.O., Couceyro P.R., Lambert P.D., and Kuhar M.J. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J. Comp. Neurol. 391 1 (1998) 115-132
14. Kristensen P., Judge M., Thim L., Ribel U., Christjansen K., Wulff B.S., Clausen J.T., Jensen P.J., and Harstrup S. The hypothalamic peptide CART is regulated by leptin and counteracts NPY induced feeding. Nature 393 (1998) 72-76
15. Kuhar M.J., Adams L.J., Hunter R.G., Vechia S.D., and Smith Y. Invited review: CART peptides. Regulatory Peptides 89 (2000) 1-6
16. Larsen P.J., Vrang N., Petersen P.C., and Kristensen P. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Obes. Res. 8 (2000) 590-596
17. Lowenstein D.H., Massa S.M., Rowbotham M.C., Collins S.D., McKinney H.E., and Simon R.P. Acute neurologic and psychiatric complications associated with cocaine abuse. Am. J. Med. 83 (1987) 841-846
18. Mileva-Seitz V.R., Louis R.P., and Stephenson R. A visual aid for computer-based analysis of sleep-wake state in rats. J. Neurosci. Methods 148 (2005) 43-48
19. Murphy K.G., Abbott C.R., Mahmoudi M., Hunter R., Gardiner J.V., Rossi M., Stanley S.A., Ghatei M.A., Kuhar M.J., and Bloom S.R. Quantification and synthesis of cocaine- and amphetamine-regulated transcript peptide (79-102)-like immunoreactivity and mRNA in rat tissues. J. Endocrinol. 166 3 (2000) 659-668
20. Murphy K.G. Dissecting the role of cocaine- and amphetamine-regulated transcript (CART) in the control of appetite. Brief Funct. Genomic Proteom. 4 2 (2005) 95-111
21. Sheih K.-R. Effects of cocaine- and amphetamine-regulated transcript peptide in the turnover of central dopaminergic neurons. Neuropharmacology 44 (2003) 940-948
22. Van Gelder R.N., Edgar D.M., and Dement W. Real-time automated sleep scoring: validation of a microcomputer-based system for mice. Sleep 14 1 (1991) 48-55
23. Vrang N., Tang-Christensen M., Larsen P.J., and Kristensen P. Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res. 818 (1999) 499-509
24. Weinshenker D., and Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol. Therapeut. 94 (2002) 213-233
25. Yang S.C., Pan J.T., and Li H.Y. CART peptide increases the mesolimbic dopaminergic neuronal activity: a microdialysis study. Eur. J. Pharmacol. 494 (2004) 179-182
26. Zagnoni P.G., and Albano C. Psychostimulants and epilepsy. Epilepsia 43 Suppl. 2 (2002) 28-31